...
首页> 外文期刊>Cellular and Molecular Neurobiology >Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis.
【24h】

Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis.

机译:伊朗多发性硬化症患者的HLA DR2&DQ6(DRB1 * 1501,DQA1 * 0102,DQB1 * 0602)单倍型分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Multiple sclerosis (MS) is prototype of inflammatory demyelinating disease of the central nervous system .The etiology of MS remains unclear, but according to current data the disease develops in genetically susceptible individuals and may require additional environmental triggers. The human leukocyte antigen (HLA) class II alleles (DRB1*1501, DQA1*0102, DQB1*0602) may have the strongest genetic effect in MS. In this study, the role of these alleles were investigated in 183 Iranian patients with multiple sclerosis and compared with 100 healthy individuals. HLA typing for DRB1*1501, DQA1*0102, DQB1*0602 was performed by polymerase chain reaction (PCR) amplification with sequence-specific primers (PCR-SSP) method. The results show that, HLA DR B1*1501 was significantly more frequent among MS patients (46% vs. 20%, PV = 0.0006) but DQA1*0102 haplotype was negatively associated with MS (30% vs. 50%, PV = 0.0049) and no significant association was found with DQB1*0602 and MS patients in comparison with control group (24% and 30%, PV = 0.43). No significant correlation was observed among these alleles with sex, type of disease; initial symptoms, expanded disability status scale (EDSS), as well as age at onset and familial MS. This study therefore indicates that there is no association of above HLA haplotypes with clinical presentation, disease duration, and disability in Iranian patients with MS which is in line with other previous studies in different ethnic groups.
机译:多发性硬化症(MS)是中枢神经系统炎性脱髓鞘疾病的原型.MS的病因尚不清楚,但根据目前的数据,该疾病在遗传易感人群中发展,可能需要其他环境诱因。人类白细胞抗原(HLA)II类等位基因(DRB1 * 1501,DQA1 * 0102,DQB1 * 0602)在MS中可能具有最强的遗传作用。在这项研究中,这些等位基因的作用在183名伊朗多发性硬化症患者中进行了调查,并与100名健康个体进行了比较。通过使用序列特异性引物(PCR-SSP)的聚合酶链反应(PCR)扩增,进行DRB1 * 1501,DQA1 * 0102,DQB1 * 0602的HLA分型。结果显示,MS患者中HLA DR B1 * 1501的发生率明显更高(46%vs. 20%,PV = 0.0006),但DQA1 * 0102单倍型与MS呈负相关(30%vs. 50%,PV = 0.0049) ),与对照组相比,DQB1 * 0602和MS患者之间没有显着相关性(24%和30%,PV = 0.43)。在这些等位基因与性别,疾病类型之间未发现显着相关性。初始症状,扩大的残疾状态量表(EDSS)以及发病年龄和家族性MS。因此,这项研究表明,伊朗MS患者中上述HLA单倍型与临床表现,疾病持续时间和残疾没有关联,这与先前在不同种族中的其他研究一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号